Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Schmidt, Sonja ^a   Gericke, Birthe ^a   Fracasso, Giulio ^b   Ramarli, Dunia ^b   Colombatti, Marco ^b   Naim, Hassan Y ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RAC1 PROTEIN; RANTES; RAS PROTEIN; TRITON X 100; CROSS LINKING REAGENT; DETERGENT; LUBROL; MACROGOL DERIVATIVE; OCTOXINOL; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CCL5 GENE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DETERGENT RESISTANT MEMBRANE; DIMERIZATION; ENDOCYTOSIS; ENZYME ACTIVATION; GENE; GENE EXPRESSION REGULATION; INTERLEUKIN 6 GENE; INTERNALIZATION; MEMBRANE BIOLOGY; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION; UPREGULATION; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; HUMAN; MALE; MAPK SIGNALING; METABOLISM; PROSTATE TUMOR; PROTEIN MULTIMERIZATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CROSS-LINKING REAGENTS; DETERGENTS; ENDOCYTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; OCTOXYNOL; POLYETHYLENE GLYCOLS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN MULTIMERIZATION;

EID: 84879226476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066193     Document Type: Article

References (35)

1. Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, et al. (1996) Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 2: 1445-1451.
2. Horoszewicz JS, Kawinski E, Murphy GP, (1987) Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7: 927-935.
3. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD, (1994) Expression of the prostate-specific membrane antigen. Cancer Res 54: 1807-1811.
4. Israeli RS, Powell CT, Fair WR, Heston WD, (1993) Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227-230.
5. Wright GL Jr, Grob BM, Haley C, Grossman K, Newhall K, et al. (1996) Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 48: 326-334.
6. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C, (1997) Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3: 81-85.
7. Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, et al. (2003) Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 9: 6357-6362.
8. Chang SS, O'Keefe DS, Bacich DJ, Reuter VE, Heston WD, et al. (1999) Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 5: 2674-2681.
9. Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, et al. (1999) Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59: 3192-3198.
10. Fracasso G, Bellisola G, Cingarlini S, Castelletti D, Prayer-Galetti T, et al. (2002) Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. Prostate 53: 9-23.
11. Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, et al. (2003) Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol 170: 1717-1721.
12. Nanus DM, Milowsky MI, Kostakoglu L, Smith-Jones PM, Vallabahajosula S, et al. (2003) Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. J Urol 170: S84-88; discussion S88-89.
13. Ballangrud AM, Yang WH, Charlton DE, McDevitt MR, Hamacher KA, et al. (2001) Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591). Cancer Res 61: 2008-2014.
14. McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, et al. (2000) An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res 60: 6095-6100.
15. Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S, et al. (1998) Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res 58: 4055-4060.
16. Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH, et al. (2003) Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res 63: 2645-2648.
17. Anilkumar G, Barwe SP, Christiansen JJ, Rajasekaran SA, Kohn DB, et al. (2006) Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature. Microvasc Res 72: 54-61.
18. Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, et al. (2003) A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell 14: 4835-4845.
19. Simons K, Gerl MJ, (2010) Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 11: 688-699.
20. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K, (2003) Resistance of cell membranes to different detergents. Proc Natl Acad Sci U S A 100: 5795-5800.
21. Castelletti D, Alfalah M, Heine M, Hein Z, Schmitte R, et al. (2008) Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes. Biochem J 409: 149-157.
22. Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, et al. (2009) The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One 4: e4608.
23. Simons K, Ikonen E, (1997) Functional rafts in cell membranes. Nature 387: 569-572.
24. Simons K, Toomre D, (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39.
25. Friedrichson T, Kurzchalia TV, (1998) Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394: 802-805.
26. Schroeder RJ, Ahmed SN, Zhu Y, London E, Brown DA, (1998) Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains. J Biol Chem 273: 1150-1157.
27. Goodman OB Jr, Barwe SP, Ritter B, McPherson PS, Vasko AJ, et al. (2007) Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2. Int J Oncol 31: 1199-1203.
28. Landers KA, Burger MJ, Tebay MA, Purdie DM, Scells B, et al. (2005) Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int J Cancer 114: 950-956.
29. Schulke N, Varlamova OA, Donovan GP, Ma D, Gardner JP, et al. (2003) The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc Natl Acad Sci U S A 100: 12590-12595.
30. Ikonen E, (2001) Roles of lipid rafts in membrane transport. Curr Opin Cell Biol 13: 470-477.
31. Barinka C, Hlouchova K, Rovenska M, Majer P, Dauter M, et al. (2008) Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs. J Mol Biol 376: 1438-1450.
32. Anderson MO, Wu LY, Santiago NM, Moser JM, Rowley JA, et al. (2007) Substrate specificity of prostate-specific membrane antigen. Bioorg Med Chem 15: 6678-6686.
33. Marta CB, Montano MB, Taylor CM, Taylor AL, Bansal R, et al. (2005) Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. J Biol Chem 280: 8985-8993.
34. Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, et al. (2003) Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci 23: 5461-5471.
35. Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, et al. (2005) N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther 4: 704-714.